The post ADA26: T1 and T2 diabetes readouts from Roche, MannKind and Lilly appeared first on Clinical Trials Arena.
ADA26: T1 and T2 diabetes readouts from Roche, MannKind and Lilly
At the American Diabetes Association (ADA) conference 2026, Roche, Lilly and others presented data. At the American Diabetes Association (ADA) conference 2026, Roche, Lilly and others presented data. There were a number of sessions for upcoming T1D and T2D candidates presented at ADA 2026. Credit: Shidlovski / iStock via Getty Images The past weekend has seen a number of major data presentations at the American Diabetes Association (ADA) conference 2026. While Clinical Trials Arena already wrapped up the major obesity readouts , there were also significant updates in the type 1 and type 2 diabetes space, including data readouts from…
At the American Diabetes Association (ADA) conference 2026, Roche, Lilly and others presented data.
Source: Clinical Trials Arena